APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Antibacterial Prescription Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Antibacterial Prescription Drugs Market Outlook and Growth Opportunities 2026

Report ID 174045920423 December 2025212 pages

Choose your research edition.

Industry ResearchVeterinary Antibacterial Prescription Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Antibacterial Prescription Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Veterinary Antibacterial Prescription Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Antibacterial Prescription Drugs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Antibacterial Prescription Drugs Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Veterinary Antibacterial Prescription Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Antibacterial Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Antibacterial Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Antibacterial Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Antibacterial Prescription Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Antibacterial Prescription Drugs market include China Animal Health And Resource, Zoetis, Shandong Lukang Shelile Pharmaceutical, Ripud Biotech, Qilu Pharmaceutical, North China Pharmaceutical, Dalian Sanyi Animal Pharmaceutical, ZyVet and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Antibacterial Prescription Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Antibacterial Prescription Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Antibacterial Prescription Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Antibacterial Prescription Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Antibacterial Prescription Drugs Segment by Company

China Animal Health And Resource

Zoetis

Shandong Lukang Shelile Pharmaceutical

Ripud Biotech

Qilu Pharmaceutical

North China Pharmaceutical

Dalian Sanyi Animal Pharmaceutical

ZyVet

Virbac

Vetoquinol

Randolph And Scott

Pharmaq

PetMed Express

Norbrook Laboratories

Merial

Merck Animal Health

Heska

Elanco Animal Health

Dechra Pharmaceuticals

Ceva Sante Animale

Boehringer Ingelheim Animal Health

Veterinary Antibacterial Prescription Drugs Segment by Type

Beta-Lactams

Aminoglycosides

Macrolides

Fluoroquinolones

Sulphonamides

Tetracyclines

Others

Veterinary Antibacterial Prescription Drugs Segment by Application

Animal Medicine Research

Animal Husbandry

Pet Medical

Others

Veterinary Antibacterial Prescription Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Antibacterial Prescription Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Antibacterial Prescription Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Antibacterial Prescription Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Antibacterial Prescription Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Antibacterial Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Antibacterial Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Antibacterial Prescription Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Antibacterial Prescription Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Antibacterial Prescription Drugs industry.

Chapter 3: Detailed analysis of Veterinary Antibacterial Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Antibacterial Prescription Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Antibacterial Prescription Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Antibacterial Prescription Drugs Industry Trends Table 2. Veterinary Antibacterial Prescription Drugs Industry Drivers Table 3. Veterinary Antibacterial Prescription Drugs Industry Opportunities and Challenges Table 4. Veterinary Antibacterial Prescription Drugs Industry Restraints Table 5. Global Veterinary Antibacterial Prescription Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Antibacterial Prescription Drugs Revenue Share by Company (2021-2026) Table 7. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Company (units) & (2021-2026) Table 8. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Antibacterial Prescription Drugs Average Price (USD/unit) of Company (2021-2026) Table 10. Global Veterinary Antibacterial Prescription Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Antibacterial Prescription Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Antibacterial Prescription Drugs Company, Product Type & Application Table 13. Global Veterinary Antibacterial Prescription Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Antibacterial Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Beta-Lactams Table 18. Significant Companies of Aminoglycosides Table 19. Significant Companies of Macrolides Table 20. Significant Companies of Fluoroquinolones Table 21. Significant Companies of Sulphonamides Table 22. Significant Companies of Tetracyclines Table 23. Significant Companies of Others Table 24. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 25. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type (2021-2026) & (units) Table 26. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type (2027-2032) & (units) Table 27. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Type (2021-2026) Table 28. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Type (2027-2032) Table 29. Global Veterinary Antibacterial Prescription Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Veterinary Antibacterial Prescription Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Veterinary Antibacterial Prescription Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Type (2021-2026) Table 33. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Animal Medicine Research Table 35. Significant Companies of Animal Husbandry Table 36. Significant Companies of Pet Medical Table 37. Significant Companies of Others Table 38. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 39. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application (2021-2026) & (units) Table 40. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application (2027-2032) & (units) Table 41. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Application (2021-2026) Table 42. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Application (2027-2032) Table 43. Global Veterinary Antibacterial Prescription Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Veterinary Antibacterial Prescription Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Veterinary Antibacterial Prescription Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Application (2021-2026) Table 47. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Application (2027-2032) Table 48. Global Veterinary Antibacterial Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Table 49. Global Veterinary Antibacterial Prescription Drugs Sales by Region (2021-2026) & (units) Table 50. Global Veterinary Antibacterial Prescription Drugs Sales Market Share by Region (2021-2026) Table 51. Global Veterinary Antibacterial Prescription Drugs Sales by Region (2027-2032) & (units) Table 52. Global Veterinary Antibacterial Prescription Drugs Sales Market Share by Region (2027-2032) Table 53. Global Veterinary Antibacterial Prescription Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Veterinary Antibacterial Prescription Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Region (2021-2026) Table 56. Global Veterinary Antibacterial Prescription Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Region (2027-2032) Table 58. Global Veterinary Antibacterial Prescription Drugs Market Average Price (USD/unit) by Region (2021-2026) Table 59. Global Veterinary Antibacterial Prescription Drugs Market Average Price (USD/unit) by Region (2027-2032) Table 60. Global Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Table 61. Global Veterinary Antibacterial Prescription Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026) & (units) Table 63. Global Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2021-2026) Table 64. Global Veterinary Antibacterial Prescription Drugs Sales by Country (2027-2032) & (units) Table 65. Global Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2027-2032) Table 66. Global Veterinary Antibacterial Prescription Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Veterinary Antibacterial Prescription Drugs Sales Value Market Share by Country (2021-2026) Table 68. Global Veterinary Antibacterial Prescription Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Veterinary Antibacterial Prescription Drugs Sales Value Market Share by Country (2027-2032) Table 70. China Animal Health And Resource Company Information Table 71. China Animal Health And Resource Business Overview Table 72. China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Product Portfolio Table 74. China Animal Health And Resource Recent Development Table 75. Zoetis Company Information Table 76. Zoetis Business Overview Table 77. Zoetis Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Zoetis Veterinary Antibacterial Prescription Drugs Product Portfolio Table 79. Zoetis Recent Development Table 80. Shandong Lukang Shelile Pharmaceutical Company Information Table 81. Shandong Lukang Shelile Pharmaceutical Business Overview Table 82. Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 84. Shandong Lukang Shelile Pharmaceutical Recent Development Table 85. Ripud Biotech Company Information Table 86. Ripud Biotech Business Overview Table 87. Ripud Biotech Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Ripud Biotech Veterinary Antibacterial Prescription Drugs Product Portfolio Table 89. Ripud Biotech Recent Development Table 90. Qilu Pharmaceutical Company Information Table 91. Qilu Pharmaceutical Business Overview Table 92. Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 94. Qilu Pharmaceutical Recent Development Table 95. North China Pharmaceutical Company Information Table 96. North China Pharmaceutical Business Overview Table 97. North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 99. North China Pharmaceutical Recent Development Table 100. Dalian Sanyi Animal Pharmaceutical Company Information Table 101. Dalian Sanyi Animal Pharmaceutical Business Overview Table 102. Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 104. Dalian Sanyi Animal Pharmaceutical Recent Development Table 105. ZyVet Company Information Table 106. ZyVet Business Overview Table 107. ZyVet Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. ZyVet Veterinary Antibacterial Prescription Drugs Product Portfolio Table 109. ZyVet Recent Development Table 110. Virbac Company Information Table 111. Virbac Business Overview Table 112. Virbac Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Virbac Veterinary Antibacterial Prescription Drugs Product Portfolio Table 114. Virbac Recent Development Table 115. Vetoquinol Company Information Table 116. Vetoquinol Business Overview Table 117. Vetoquinol Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Vetoquinol Veterinary Antibacterial Prescription Drugs Product Portfolio Table 119. Vetoquinol Recent Development Table 120. Randolph And Scott Company Information Table 121. Randolph And Scott Business Overview Table 122. Randolph And Scott Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Randolph And Scott Veterinary Antibacterial Prescription Drugs Product Portfolio Table 124. Randolph And Scott Recent Development Table 125. Pharmaq Company Information Table 126. Pharmaq Business Overview Table 127. Pharmaq Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Pharmaq Veterinary Antibacterial Prescription Drugs Product Portfolio Table 129. Pharmaq Recent Development Table 130. PetMed Express Company Information Table 131. PetMed Express Business Overview Table 132. PetMed Express Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. PetMed Express Veterinary Antibacterial Prescription Drugs Product Portfolio Table 134. PetMed Express Recent Development Table 135. Norbrook Laboratories Company Information Table 136. Norbrook Laboratories Business Overview Table 137. Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Product Portfolio Table 139. Norbrook Laboratories Recent Development Table 140. Merial Company Information Table 141. Merial Business Overview Table 142. Merial Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Merial Veterinary Antibacterial Prescription Drugs Product Portfolio Table 144. Merial Recent Development Table 145. Merck Animal Health Company Information Table 146. Merck Animal Health Business Overview Table 147. Merck Animal Health Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Merck Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio Table 149. Merck Animal Health Recent Development Table 150. Heska Company Information Table 151. Heska Business Overview Table 152. Heska Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Heska Veterinary Antibacterial Prescription Drugs Product Portfolio Table 154. Heska Recent Development Table 155. Elanco Animal Health Company Information Table 156. Elanco Animal Health Business Overview Table 157. Elanco Animal Health Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Elanco Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio Table 159. Elanco Animal Health Recent Development Table 160. Dechra Pharmaceuticals Company Information Table 161. Dechra Pharmaceuticals Business Overview Table 162. Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Product Portfolio Table 164. Dechra Pharmaceuticals Recent Development Table 165. Ceva Sante Animale Company Information Table 166. Ceva Sante Animale Business Overview Table 167. Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Product Portfolio Table 169. Ceva Sante Animale Recent Development Table 170. Boehringer Ingelheim Animal Health Company Information Table 171. Boehringer Ingelheim Animal Health Business Overview Table 172. Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio Table 174. Boehringer Ingelheim Animal Health Recent Development Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Veterinary Antibacterial Prescription Drugs Distributors List Table 178. Veterinary Antibacterial Prescription Drugs Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Veterinary Antibacterial Prescription Drugs Product Image Figure 2. Global Veterinary Antibacterial Prescription Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Antibacterial Prescription Drugs Sales (2021-2032) & (units) Figure 5. Global Veterinary Antibacterial Prescription Drugs Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Veterinary Antibacterial Prescription Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Beta-Lactams Image Figure 10. Aminoglycosides Image Figure 11. Macrolides Image Figure 12. Fluoroquinolones Image Figure 13. Sulphonamides Image Figure 14. Tetracyclines Image Figure 15. Others Image Figure 16. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 17. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Type (2021-2032) Figure 19. Global Veterinary Antibacterial Prescription Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Veterinary Antibacterial Prescription Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Type (2021-2032) Figure 22. Animal Medicine Research Image Figure 23. Animal Husbandry Image Figure 24. Pet Medical Image Figure 25. Others Image Figure 26. Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 27. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Application (2021-2032) Figure 29. Global Veterinary Antibacterial Prescription Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Veterinary Antibacterial Prescription Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Application (2021-2032) Figure 32. Global Veterinary Antibacterial Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 33. Global Veterinary Antibacterial Prescription Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Veterinary Antibacterial Prescription Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. North America Veterinary Antibacterial Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Veterinary Antibacterial Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. South America Veterinary Antibacterial Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Veterinary Antibacterial Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Veterinary Antibacterial Prescription Drugs Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Veterinary Antibacterial Prescription Drugs Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Beta-Lactams
  • Aminoglycosides
  • Macrolides
  • Fluoroquinolones
  • Sulphonamides
  • Tetracyclines
  • Others
Applications
  • Animal Medicine Research
  • Animal Husbandry
  • Pet Medical
  • Others
Companies covered
  • China Animal Health And Resource
  • Zoetis
  • Shandong Lukang Shelile Pharmaceutical
  • Ripud Biotech
  • Qilu Pharmaceutical
  • North China Pharmaceutical
  • Dalian Sanyi Animal Pharmaceutical
  • ZyVet
  • Virbac
  • Vetoquinol
  • Randolph And Scott
  • Pharmaq
  • PetMed Express
  • Norbrook Laboratories
  • Merial
  • Merck Animal Health
  • Heska
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Antibacterial Prescription Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Antibacterial Prescription Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Antibacterial Prescription Drugs Market Dynamics
  1. 2.1 Veterinary Antibacterial Prescription Drugs Industry Trends
  2. 2.2 Veterinary Antibacterial Prescription Drugs Industry Drivers
  3. 2.3 Veterinary Antibacterial Prescription Drugs Industry Opportunities and Challenges
  4. 2.4 Veterinary Antibacterial Prescription Drugs Industry Restraints
3 Veterinary Antibacterial Prescription Drugs Market by Company
  1. 3.1 Global Veterinary Antibacterial Prescription Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Antibacterial Prescription Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Antibacterial Prescription Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Antibacterial Prescription Drugs Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Antibacterial Prescription Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Antibacterial Prescription Drugs Company Product Type and Application
  8. 3.8 Global Veterinary Antibacterial Prescription Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Antibacterial Prescription Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Antibacterial Prescription Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Antibacterial Prescription Drugs Market by Type
  1. 4.1 Veterinary Antibacterial Prescription Drugs Type Introduction
  2. 4.1.1 Beta-Lactams
  3. 4.1.2 Aminoglycosides
  4. 4.1.3 Macrolides
  5. 4.1.4 Fluoroquinolones
  6. 4.1.5 Sulphonamides
  7. 4.1.6 Tetracyclines
  8. 4.1.7 Others
  9. 4.2 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type
  10. 4.2.1 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Veterinary Antibacterial Prescription Drugs Sales Value by Type
  14. 4.3.1 Global Veterinary Antibacterial Prescription Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Veterinary Antibacterial Prescription Drugs Sales Value by Type (2021-2032)
  16. 4.3.3 Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Type (2021-2032)
5 Veterinary Antibacterial Prescription Drugs Market by Application
  1. 5.1 Veterinary Antibacterial Prescription Drugs Application Introduction
  2. 5.1.1 Animal Medicine Research
  3. 5.1.2 Animal Husbandry
  4. 5.1.3 Pet Medical
  5. 5.1.4 Others
  6. 5.2 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application
  7. 5.2.1 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Veterinary Antibacterial Prescription Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Veterinary Antibacterial Prescription Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Veterinary Antibacterial Prescription Drugs Sales Value by Application
  11. 5.3.1 Global Veterinary Antibacterial Prescription Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Veterinary Antibacterial Prescription Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Veterinary Antibacterial Prescription Drugs Sales Value Share by Application (2021-2032)
6 Veterinary Antibacterial Prescription Drugs Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Antibacterial Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Antibacterial Prescription Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Antibacterial Prescription Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Antibacterial Prescription Drugs Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Antibacterial Prescription Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Antibacterial Prescription Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Antibacterial Prescription Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Antibacterial Prescription Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Antibacterial Prescription Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Antibacterial Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Antibacterial Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Antibacterial Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Antibacterial Prescription Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Antibacterial Prescription Drugs Sales Value Share by Country, 2025 VS 2032
7 Veterinary Antibacterial Prescription Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Antibacterial Prescription Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Antibacterial Prescription Drugs Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Antibacterial Prescription Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Antibacterial Prescription Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Antibacterial Prescription Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Antibacterial Prescription Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Antibacterial Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Antibacterial Prescription Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Animal Health And Resource
  2. 8.1.1 China Animal Health And Resource Company Information
  3. 8.1.2 China Animal Health And Resource Business Overview
  4. 8.1.3 China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Product Portfolio
  6. 8.1.5 China Animal Health And Resource Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Veterinary Antibacterial Prescription Drugs Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Shandong Lukang Shelile Pharmaceutical
  14. 8.3.1 Shandong Lukang Shelile Pharmaceutical Company Information
  15. 8.3.2 Shandong Lukang Shelile Pharmaceutical Business Overview
  16. 8.3.3 Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  18. 8.3.5 Shandong Lukang Shelile Pharmaceutical Recent Developments
  19. 8.4 Ripud Biotech
  20. 8.4.1 Ripud Biotech Company Information
  21. 8.4.2 Ripud Biotech Business Overview
  22. 8.4.3 Ripud Biotech Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ripud Biotech Veterinary Antibacterial Prescription Drugs Product Portfolio
  24. 8.4.5 Ripud Biotech Recent Developments
  25. 8.5 Qilu Pharmaceutical
  26. 8.5.1 Qilu Pharmaceutical Company Information
  27. 8.5.2 Qilu Pharmaceutical Business Overview
  28. 8.5.3 Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  30. 8.5.5 Qilu Pharmaceutical Recent Developments
  31. 8.6 North China Pharmaceutical
  32. 8.6.1 North China Pharmaceutical Company Information
  33. 8.6.2 North China Pharmaceutical Business Overview
  34. 8.6.3 North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  36. 8.6.5 North China Pharmaceutical Recent Developments
  37. 8.7 Dalian Sanyi Animal Pharmaceutical
  38. 8.7.1 Dalian Sanyi Animal Pharmaceutical Company Information
  39. 8.7.2 Dalian Sanyi Animal Pharmaceutical Business Overview
  40. 8.7.3 Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  42. 8.7.5 Dalian Sanyi Animal Pharmaceutical Recent Developments
  43. 8.8 ZyVet
  44. 8.8.1 ZyVet Company Information
  45. 8.8.2 ZyVet Business Overview
  46. 8.8.3 ZyVet Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ZyVet Veterinary Antibacterial Prescription Drugs Product Portfolio
  48. 8.8.5 ZyVet Recent Developments
  49. 8.9 Virbac
  50. 8.9.1 Virbac Company Information
  51. 8.9.2 Virbac Business Overview
  52. 8.9.3 Virbac Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Virbac Veterinary Antibacterial Prescription Drugs Product Portfolio
  54. 8.9.5 Virbac Recent Developments
  55. 8.10 Vetoquinol
  56. 8.10.1 Vetoquinol Company Information
  57. 8.10.2 Vetoquinol Business Overview
  58. 8.10.3 Vetoquinol Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Vetoquinol Veterinary Antibacterial Prescription Drugs Product Portfolio
  60. 8.10.5 Vetoquinol Recent Developments
  61. 8.11 Randolph And Scott
  62. 8.11.1 Randolph And Scott Company Information
  63. 8.11.2 Randolph And Scott Business Overview
  64. 8.11.3 Randolph And Scott Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Randolph And Scott Veterinary Antibacterial Prescription Drugs Product Portfolio
  66. 8.11.5 Randolph And Scott Recent Developments
  67. 8.12 Pharmaq
  68. 8.12.1 Pharmaq Company Information
  69. 8.12.2 Pharmaq Business Overview
  70. 8.12.3 Pharmaq Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Pharmaq Veterinary Antibacterial Prescription Drugs Product Portfolio
  72. 8.12.5 Pharmaq Recent Developments
  73. 8.13 PetMed Express
  74. 8.13.1 PetMed Express Company Information
  75. 8.13.2 PetMed Express Business Overview
  76. 8.13.3 PetMed Express Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 PetMed Express Veterinary Antibacterial Prescription Drugs Product Portfolio
  78. 8.13.5 PetMed Express Recent Developments
  79. 8.14 Norbrook Laboratories
  80. 8.14.1 Norbrook Laboratories Company Information
  81. 8.14.2 Norbrook Laboratories Business Overview
  82. 8.14.3 Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Product Portfolio
  84. 8.14.5 Norbrook Laboratories Recent Developments
  85. 8.15 Merial
  86. 8.15.1 Merial Company Information
  87. 8.15.2 Merial Business Overview
  88. 8.15.3 Merial Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Merial Veterinary Antibacterial Prescription Drugs Product Portfolio
  90. 8.15.5 Merial Recent Developments
  91. 8.16 Merck Animal Health
  92. 8.16.1 Merck Animal Health Company Information
  93. 8.16.2 Merck Animal Health Business Overview
  94. 8.16.3 Merck Animal Health Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Merck Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio
  96. 8.16.5 Merck Animal Health Recent Developments
  97. 8.17 Heska
  98. 8.17.1 Heska Company Information
  99. 8.17.2 Heska Business Overview
  100. 8.17.3 Heska Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Heska Veterinary Antibacterial Prescription Drugs Product Portfolio
  102. 8.17.5 Heska Recent Developments
  103. 8.18 Elanco Animal Health
  104. 8.18.1 Elanco Animal Health Company Information
  105. 8.18.2 Elanco Animal Health Business Overview
  106. 8.18.3 Elanco Animal Health Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Elanco Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio
  108. 8.18.5 Elanco Animal Health Recent Developments
  109. 8.19 Dechra Pharmaceuticals
  110. 8.19.1 Dechra Pharmaceuticals Company Information
  111. 8.19.2 Dechra Pharmaceuticals Business Overview
  112. 8.19.3 Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Product Portfolio
  114. 8.19.5 Dechra Pharmaceuticals Recent Developments
  115. 8.20 Ceva Sante Animale
  116. 8.20.1 Ceva Sante Animale Company Information
  117. 8.20.2 Ceva Sante Animale Business Overview
  118. 8.20.3 Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Product Portfolio
  120. 8.20.5 Ceva Sante Animale Recent Developments
  121. 8.21 Boehringer Ingelheim Animal Health
  122. 8.21.1 Boehringer Ingelheim Animal Health Company Information
  123. 8.21.2 Boehringer Ingelheim Animal Health Business Overview
  124. 8.21.3 Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio
  126. 8.21.5 Boehringer Ingelheim Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Antibacterial Prescription Drugs Value Chain Analysis
  2. 9.1.1 Veterinary Antibacterial Prescription Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Antibacterial Prescription Drugs Sales Mode & Process
  6. 9.2 Veterinary Antibacterial Prescription Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Antibacterial Prescription Drugs Distributors
  9. 9.2.3 Veterinary Antibacterial Prescription Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst